FEATURED CONTRIBUTED CONTENT

DIA 2015 Editor’s Take – BBK Worldwide – Brescia & Aprigliano


DIA 2015 Editor’s Take – BBK Worldwide – Brescia & Aprigliano

Bonnie Brescia and Christel Aprigliano discuss the past, present, and future of patient centricity.

July 29, 2015More Clinical »
DIA 2015 Editor’s Take – BBK Worldwide – Brescia & Meunier


DIA 2015 Editor’s Take – BBK Worldwide – Brescia & Meunier

Bonnie Brescia and Claire Meunier talk about integrating the patient voice in clinical research, and how wearables, ingestibles, and other technologies are supporting patient centricity.

July 29, 2015More Clinical »
DIA 2015 Editor’s Take – ArisGlobal


DIA 2015 Editor’s Take – ArisGlobal

David Laky provides an overview on integrated solutions in clinical development systems and their impact on the future of clinical research.

July 29, 2015More Clinical »
Hiding in Plain Sight – Co-Pay as the Key to Patient Engagement


Hiding in Plain Sight – Co-Pay as the Key to Patient Engagement

In this episode, Paul LeVine talks about co-pay, patient affordability, and patient engagement.  There’s also a related whitepaper on this topic, which you can download from the link below.

August 17, 2015More Clinical »
DIA 2015 Editor’s Take – ACM Global Central Laboratory


DIA 2015 Editor’s Take – ACM Global Central Laboratory

Mark Engelhart of ACM discusses clinical trials protocols, diagnostic testing, risk-based monitoring, and adaptive trials.

July 30, 2015More Clinical »
Specialized online medical communities: Uncover insights and Engage targeted HCP audiences


Specialized online medical communities: Uncover insights and Engage targeted HCP audiences

In this episode, we meet with Dr. Theodore Search, PharmD, Founder and CEO of Skipta.  We talk about why Skipta was started.  We discuss the move to a patient centric model in the industry, how this impacts the dynamics of online medical communities, and finally, measuring success and interacting with these online communities.

August 21, 2015More Clinical »
Leveraging Patient Feedback Data to Support Effectiveness and Demonstrate Outcomes


Leveraging Patient Feedback Data to Support Effectiveness and Demonstrate Outcomes

As the healthcare landscape moves increasingly toward outcome-based treatment approaches, the need to gather and analyze real-world outcome data has become paramount to gauging medication effectiveness and subsequently recruiting prescribers as brand advocates. This study outlines a feedback program that provides prescribers with patient results of their treatment experience in order to better inform their therapy recommendations. The program […]

August 24, 2015More Clinical »
DIA 2015 Editor’s Take – TKL Research, Inc.


DIA 2015 Editor’s Take – TKL Research, Inc.

Lynn King shares some misconceptions about risk-based monitoring and offers alternative clinical monitoring strategies using RBM.

July 29, 2015More Clinical »
DIA 2015 Editor’s Take – Celerion


DIA 2015 Editor’s Take – Celerion

Drs. Pritchard and Chee discuss Celerion’s expansion into South Korea, KoNECT’s role in fostering clinical research in South Korea, and the advantages of conducting clinical research in South Korea.

July 29, 2015More Clinical »
Blinding of Investigational Products – part of the Clinical Supply Knowledge Share Series


Blinding of Investigational Products – part of the Clinical Supply Knowledge Share Series

Part 1 of the Clinical Supply Knowledge Share Series by Almac. Blinding of Investigational Products – Highlights: The Changing Product Landscape Common Trial Designs Blinding Methods – Drug Encapsulation Blinding Methods – Inhalers Other Dosage Forms – Consideration Checklists Almac’s Approach to Blinding Download this informative ebook now.

August 1, 2015More Clinical »
Script Abandonment: Untangling Influences Across the Patient Journey


Script Abandonment: Untangling Influences Across the Patient Journey

Claims data highlight a portion of script abandonment, but don’t capture patients who never get to the pharmacy. Zitter Health Insights’ new and innovative research on script abandonment not only captures all types of abandonment, including before patients even get to the pharmacy, but also provides you with the “why.” How often is abandonment mindful […]

July 31, 2015More Clinical »
DIA 2015 Editor’s Take – HCL Technologies


DIA 2015 Editor’s Take – HCL Technologies

Abhishek Shankar discusses the value of patient-centricity and and how the cloud is transforming operations in the life-sciences industry.

July 29, 2015More Clinical »
DIA 2015 Editor’s Take – Chiltern International Inc.


DIA 2015 Editor’s Take – Chiltern International Inc.

Dr. Esinhart discusses how Chiltern’s “Designed Around You” culture supports clients’ needs, the advantages of a mid-sized global CRO, and how technology is changing the industry.

July 29, 2015More Clinical »
DIA 2015 Editor’s Take – INC Research – Townshend


DIA 2015 Editor’s Take – INC Research – Townshend

Andrew Townshend outlines the key benefits of a strategic CRO-sponsor alliance and ways to maximize the expertise from one project to the next.

July 29, 2015More Clinical »
Patient Outcomes: How Do You Make Them Complement Your Brands POA?


Patient Outcomes: How Do You Make Them Complement Your Brands POA?

In this episode, Paul LeVine talks about a shift toward focusing on outcomes and how the patient’s voice is changing healthcare.  There’s also a related whitepaper on this topic, which may be downloaded from the link below.

August 24, 2015More Clinical »
DIA 2015 Editor’s Take – Medpace


DIA 2015 Editor’s Take – Medpace

Michelle Petersen discusses why rare disease and orphan indications are unique, related challenges to development, and tips for common study execution.

July 29, 2015More Clinical »
DIA 2015 Editor’s Take – MedPoint Digital


DIA 2015 Editor’s Take – MedPoint Digital

Bill Cooney discusses how studies are becoming digital, how this impacts clinical research subjects, and how the industry needs to adapt.

July 29, 2015More Clinical »
Bringing it all Together – Two Minutes with Ken Faulkner


Bringing it all Together – Two Minutes with Ken Faulkner

PAREXEL® Informatics, Corporate Vice President Ken Faulkner discusses his company’s unique Perceptive® MyTrials solution. All along your new drug’s development path, PAREXEL® Informatics has technological innovations that make the process faster, more precise, more trackable, and more productive. PAREXEL® leads the industry in creating integrated platforms and applications specifically designed to improve how biopharmaceutical companies […]

August 13, 2015More Clinical »
DIA 2015 Editor’s Take – inVentiv Health Clinical


DIA 2015 Editor’s Take – inVentiv Health Clinical

Gregory Skalicky discusses the evolution of strategic engagements with sponsors and the benefits of working with a full-service, global CRO.

July 29, 2015More Clinical »
DIA 2015 Editor’s Take – INC Research – Burnham


DIA 2015 Editor’s Take – INC Research – Burnham

David Burnham explores ways to improve the CRO-sponsor relationship and the associated benefits of a partnership alliance and successful strategic CRO-sponsor collaboration.

July 29, 2015More Clinical »
DIA 2015 Editor’s Take – ICON


DIA 2015 Editor’s Take – ICON

Dr. Spector describes how the R&D model will change by 2025, the void in clinical research talent, and preparing for the future.

July 29, 2015More Clinical »
DIA 2015 Editor’s Take – PerkinElmer


DIA 2015 Editor’s Take – PerkinElmer

Ben McGraw of PerkinElmer discusses various trends impacting the industry from IT to data transparency and the pros and cons of virtual biotech models.

August 12, 2015More Clinical »
DIA 2015 Editor’s Take – Kelly Outsourcing and Consulting Group


DIA 2015 Editor’s Take – Kelly Outsourcing and Consulting Group

Mark Lanfear of Kelly Outsourcing and Consulting Group discusses the evolving clinical trial landscape and how the talent needs within the industry are changing.

August 12, 2015More Clinical »
DIA 2015 Editor’s Take – DitaExchange


DIA 2015 Editor’s Take – DitaExchange

Jim Nichols provides an overview of structured content management (SCM) and why it’s important; he also shares examples and metrics of projects and outlines the next step in the evolution of SCM.

July 29, 2015More Clinical »
DIA 2015 Editor’s Take – ClinicalRM


DIA 2015 Editor’s Take – ClinicalRM

Joseph Sgherza outlines global trends related to clinical trials for pandemic responses, innovations in logistics, and how ClinicalRM assists in pandemic situations.

July 29, 2015More Clinical »
Hiding in Plain Sight – Could Co-Pay Programs be the Solution for Better Outcomes?


Hiding in Plain Sight – Could Co-Pay Programs be the Solution for Better Outcomes?

The healthcare industry has been wringing its collective hands for years about the problems surrounding “patient engagement.” Beyond the fact that no one has a really good definition of what constitutes patient engagement, most everyone agrees that if you have more patient engagement, you’ll achieve better outcomes. Learn more about how co-pay programs lead to better outcomes.

August 17, 2015More Clinical »
DIA 2015 Editor’s Take – PPD & HealthCore


DIA 2015 Editor’s Take – PPD & HealthCore

Michael Pollock and Mark Cziraky discuss how their two companies’ recent collaboration and combined strengths will improve real-world outcomes/evidence and Phase IV pragmatic trials.

July 29, 2015More Clinical »
DIA 2015 Editor’s Take – Hurley Consulting Associates Ltd.


DIA 2015 Editor’s Take – Hurley Consulting Associates Ltd.

Dr. Hurley discusses regulatory challenges in an era of mergers and acquisitions, FDA review practices, and managing the FDA approval process.

July 29, 2015More Clinical »
FEEDBACK